Provider of healthcare solutions Ambu A/S (CPH:AMBUB) announced on Monday that Allan Søgaard Larsen has decided to withdraw from the company's board of directors, effective immediately.
The company said Larsen, who has since 2011 has been a member of the board of directors in Ambu, is leaving for personal reasons.
Ambu develops, produces and markets life-saving equipment. The company provides professional diagnostic, life supporting and training equipment. Its products are used for respiratory support and cardiopulmonary resuscitation, immobilisation and protection against infections.
Roivant to announce Q3 2026 financial results
Avacta secures FDA clearance for second pre|CISION oncology programme
OncoHost receives BIG Innovation Award in Health category
Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy
Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer
Antin to acquire clinical trial equipment provider Emsere
Merck completes acquisition of Cidara Therapeutics for USD9.2bn
Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial
Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China
INOVIO's INO-3107 Biologics License Application accepted by US FDA
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA